Skip to main content
OpenTrials

Clinical trial condition

Acute Myelogenous Leukemia

Explore clinical trials studying Acute Myelogenous Leukemia. Study availability and eligibility vary by location and protocol.

154 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Acute Myelogenous Leukemia trial results

Completed

Dosing Study of Ara-C/EL625/Idarubicin in Refractory and Relapsed AML

NCT00074737

Conditions
Acute Myelogenous Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • University of California, San Diego La Jolla, California, United States
  • University of Miami Health Center Miami, Florida, United States
  • Washington University Medical Center (Siteman Cancer Center) St Louis, Missouri, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
View Trial Details
Completed

A Study of Clofarabine for Older Patients With Newly Diagnosed Acute Myelogenous Leukemia (AML) (CLASSIC II)

NCT00373529

Conditions
Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Hematologic Diseases, +6 more
Locations
  • Mayo Clinical Hospital Phoenix, Arizona, United States
  • Arizona Cancer Center Tucson, Arizona, United States
  • USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
  • Scripps Cancer Center San Diego, California, United States
View all 20 locations
View Trial Details
Completed

A Study of Clofarabine in Combination With Etoposide and Cyclophosphamide in Children With Acute Leukemias.

NCT00315705

Conditions
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Hematologic Diseases, +13 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital of Los Angeles Los Angeles, California, United States
  • Rady Children's Hospital San Diego, California, United States
  • Connecticut Children's Medical Center Hartford, Connecticut, United States
View all 13 locations
View Trial Details
Completed

A Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)(CLASSIC I)

NCT00317642

Conditions
Acute Myelogenous Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Mayo Clinical Hospital Scottsdale, Arizona, United States
  • Arizona Cancer Center Tucson, Arizona, United States
  • University of Arkansas for Medical Sciences, Arkansas Cancer Research Center Little Rock, Arkansas, United States
  • Scripps Cancer Center La Jolla, California, United States
View all 57 locations
View Trial Details
Completed

A Study of Clofarabine in Japanese Patients With Acute Myeloid Leukemia (AML)

NCT01090167

Conditions
Acute Myelogenous Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Nagoya Daini Red Cross Hospital Aichi, Japan
  • National Hospital Organization Nagoya Medical Center Aichi, Japan
  • University of Fukui Hospital Fukui, Japan
  • Tokai University Hospital Kanagawa, Japan
View Trial Details
Completed

MLN4924 for the Treatment of Acute Myelogenous Leukemia, Myelodysplastic Syndrome, and Acute Lymphoblastic Leukemia

NCT00911066

Conditions
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +15 more
Locations
  • Stanford University Medical Center Stanford, California, United States
  • Robert H. Lurie Comprehensive Cancer Center Northwestern University Chicago, Illinois, United States
  • Johns Hopkins Kimmel Cancer Center Baltimore, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions